Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT02561078

Public ClinicalTrials.gov record NCT02561078. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 1:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Efficacy of Human Regular U-500 Insulin Administered by Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Subjects With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Parallel Clinical Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the efficacy and safety of the study drug known as human regular U-500 insulin (U-500R) administered by continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) in participants with type 2 diabetes mellitus.

Study identification

NCT ID
NCT02561078
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
420 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 20, 2015 (Actual)
Primary completion
May 9, 2017 (Actual)
Completion
May 9, 2017 (Actual)
Last update posted
May 20, 2020

2015 – 2017

United States locations

U.S. sites
52
U.S. states
26
U.S. cities
51
Facility City State ZIP Site status
Internal Medicine Center LLC Mobile Alabama 36608 —
John Muir Physician Network Clinical Research Center Concord California 94520 —
Valley Endocrine, Fresno Fresno California 93720 —
Scripps Whittier Diabetes Institute La Jolla California 92037 —
Diabetes and Endocrine Associates La Mesa California 91942 —
First Valley Medical Group Lancaster California 93534 —
Pacific Research Partners, LLC Oakland California 94607 —
Inland Empire Liver Foundation Rialto California 92377 —
NorCal Endocrinology and Internal Medicine - Roseville Roseville California 95661 —
NorCal Endocrinology and Internal Medicine - Roseville San Ramon California 94583 —
Olive View Medical Center Sylmar California 91342 —
ALL Medical Research, LLC Cooper City Florida 33024 —
East Coast Institute For Research, LLC Jacksonville Florida 32216 —
Suncoast Clinical Research New Port Richey Florida 34652 —
Metabolic Research Institute Inc. West Palm Beach Florida 33401 —
East Coast Institute For Research, LLC Macon Georgia 31210 —
Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls Idaho 83404 —
John H. Stroger Hospital of Cook County Chicago Illinois 60612 —
Midwest CRC Crystal Lake Illinois 60012 —
HSHS Medical Group Diabetes Research Springfield Illinois 62711 —
Iderc, P.L.C. Des Moines Iowa 50314 —
Cotton O'Neil Diabetes and Endocrinology Center Topeka Kansas 66606 —
Kentucky Diabetes Endocrinology Center Lexington Kentucky 40503 —
The Arthritis & Diabetes Clinic Inc. Monroe Louisiana 71203 —
Grunberger Diabetes Institute Bloomfield Hills Michigan 48302 —
Adult Endocrinology Consultants, P.C. Livonia Michigan 48154 —
JCMG Clinical Research Jefferson City Missouri 65109 —
Billings Clinic Research Center Billings Montana 59101 —
Diabetes and Endocrinology Associates Omaha Nebraska 68114 —
Palm Research Center Las Vegas Nevada 89128 —
Palm Research Center Las Vegas Nevada 89148 —
Southern New Hampshire Diabetes and Endocrinology Nashua New Hampshire 03063 —
North Shore Diabetes and Endocrine Assoc New Hyde Park New York 11040 —
Mountain Diabetes and Endocrine Center Asheville North Carolina 28803 —
Physicians East Greenville North Carolina 27834 —
PMG Research of Rocky Mount, LLC Rocky Mount North Carolina 27804 —
University of Oklahoma Health Sciences Center-Tulsa Oklahoma City Oklahoma 73104 —
Portland Diabetes & Endocrine Center Portland Oregon 97210 —
Endocrine Metabolic Associates, P.C. Philadelphia Pennsylvania 19114 —
Partners in Nephrology & Endocrinology Pittsburgh Pennsylvania 15224 —
Sudhir Bansal M.D. Inc. Warwick Rhode Island 02886 —
AM Diabetes and Endocrinology Center Bartlett Tennessee 38133 —
University Diabetes and Endocrine Consultants Chattanooga Tennessee 37411 —
Vanderbilt Univeristy School of Medicine Nashville Tennessee 37232 —
Texas Diabetes and Endocrinology-Austin South Austin Texas 78749 —
Dallas Diabetes Endocrine Center Dallas Texas 75230 —
Texas Diabetes and Endocrinology, P.A. Round Rock Texas 78681 —
Advanced Research Institute South Ogden Utah 84405 —
Dr. Larry Stonesifer Federal Way Washington 98003 —
Rainier Clinical Research Center Renton Washington 98057 —
Northside Internal Medicine Spokane Washington 99208 —
Multicare Health System Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02561078, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 20, 2020 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02561078 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →